A reduced expression or activity of BIN1, found in various types of cancers, enables an increased IDO activity, which promotes the appearance of immunotolerance [47–49]. In vitro studies of carcinoma cells demonstrated that NaB inhibits IFN-γ-induced IDO expression by reducing the phosphorylation and nuclear translocation of STAT1 [50]. This evidence concerns the gene IDO1 and cancer.